Table 3 The Inhibition percentage of 100 µg/ml single dose of the prepared chelates, shows the anticancer effect of the prepared chelates on HCT116, hela, Caco-2, MCF-7, and A549 cell lines, the data were expressed as the mean ± SD of three independent experiments.

From: Folate-based binuclear Mn(II) chelates with 2,2’-bipyridine/1,10-phenanthroline as targeted anticancer agents for colon cancer cells

Cells

Inhibition percentage (%)

Chelate 1

Chelate 2

HCT116

79.3 ± 3.6

77.36 ± 0.55

HeLa

76.23 ± 1.1

75.03 ± 3.12

Caco-2

74.9 ± 2.33

74.49 ± 3.50

MCF-7

63.33 ± 5.11

60.84 ± 2.05

A549

57.9 ± 3.30

59.01 ± 3.02

HSF

4.7 ± 2.11

8.5 ± 1.71